Skip to main content

Table 3 Antimicrobial Susceptibility Pattern of Gram Negative Bacterial Isolates among Mekelle University Students with Symptomatic UTI, northern Ethiopia, February–September 2017

From: Bacteriological profile, risk factors and antimicrobial susceptibility patterns of symptomatic urinary tract infection among students of Mekelle University, northern Ethiopia

Bacterial Isolates(n)

Antibiotics

AMP

AMC

CTR

NX

GEN

NA

NIT

CIP

COT

TE

C

E. coli (36)

S

0(0.0)

2(5.6)

29(80.6)

30(83.3)

25(69.5)

15(41.7)

29(80.6)

30(83.3)

11(30.6)

21(58.3)

29(80.6)

I

3(8.3)

3(8.3)

0(0.0)

2(5.6)

8(22.2)

5(13.9)

2(5.6)

3(8.3)

3(8.3)

3(8.3)

0(0.0)

R

33(91.7)

31(86.1)

7(19.4)

4(11.1)

3(8.3)

16(44.4)

5(13.8)

3(8.3)

22(61.1)

12(33.3)

7(19.4)

K. pneumoniae (6)

S

0(0.0)

1(16.7)

5(83.3)

4(66.7)

4(66.7)

3(50.0)

3(50.0)

5(83.3)

1(16.7)

1(16.7)

3(50.0)

I

1(16.7)

1(16.7)

0(0.0)

1(16.7)

0(0.0)

1(16.7)

0(0.0)

1(16.7)

1(16.7)

2(33.3)

2(33.3)

R

5(83.3)

4(66.7)

1(16.7)

1(16.7)

2(33.3)

2(33.3)

3(50.0)

0(0.0)

4(66.7)

3(50.0)

1(16.7)

P. mirabilis (2)

S

0(0.0)

0(0.0)

2(100)

1(50.0)

2(100)

1(50.0)

2(100)

2(100)

1(50.0)

1(50.0)

2(100)

I

0(0.0)

1(50.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

R

2(100)

1(50.0)

0(0.0)

1(50.0)

0(0.0)

1(50.0)

0(0.0)

0(0.0)

1(50.0)

1(50.0)

0(0.0)

Citrobacter spp. (2)

S

0(0.0)

0(0.0)

2(100)

2(100)

1(50.0)

1(50.0)

2(100)

2(100)

0(0.0)

1(50.0)

1(50.0)

I

0(0.0)

0(0.0)

0(0.0)

0(0.0)

1(50.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

1(50.0)

0(0.0)

R

2(100)

2(100)

0(0.0)

0(0.0)

0(0.0)

1(50.0)

0(0.0)

0(0.0)

2(100)

0(0.0)

1(50.0)

Enterobacter spp.(1)

S

0(0.0)

0(0.0)

1(100)

1(100)

1(100)

0(0.0)

1(100)

1(100)

0(0.0)

1(100)

0(0.0)

I

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

1(100)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

1(100)

R

1(100)

1(100)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

0(0.0)

1(0.0)

0(0.0)

0(0.0)

Total n (%)

S

0(0.0)

3(6.4)

39(83.0)

38(80.8)

33(70.2)

20(42.6)

37(78.7)

40(85.1)

13(27.7)

25(53.1)

35(74.5)

I

4(8.5)

5(10.7)

0(0.0)

3(6.4)

9(19..2)

7(14.8)

2(4.3)

4(8.5)

4(8.5)

6(12.8)

3(6.4)

R

43(91.5)

39(82.9)

8(17.0)

6(12.8)

5(10.6)

20(42.6)

8(17.0)

3(6.4)

30(63.8)

16(34.0)

9(19.1)

  1. Key; AMC Amoxacillin clavulanic acid, AMP Ampicillin, NA Nalidixic acid, NX Norfloxacilin, NIT Nitrofruinton, CTR Ceftriaxone, GEN Gentamicin, COT Co-trimexazole, TE Tetracycline, C Chloramphenicol, CIP Ciprofloxacin, S Susceptible, I Intermediate, R Resistant. % is computed from each cell. Total total resistance of gram negative isolates for the specific tested